Canada-based Medicure Inc (TSXV:MPH)(OTC:MCUJF), a cardiovascular pharmaceutical company, has reported its financial results for the quarter ended 31 March 2020 on Tuesday.

The company reported total net revenue from the sale of products of USD3m during the first quarter of 2020, compared to USD4.9m in the year-ago period.

The firm posted net loss for the quarter ended 31 March 2020 at USD1.5m or USD0.14 per share compared to a net loss of USD2.8m or USD0.18 per share for the same period in 2019.